This policy watch discusses a recent Tennessee law that requires the sharing of data for applicants and/or enrollees for the state’s public assistance programs who do not have a qualified immigration status with immigration authorities, including for those enrolled in the state’s Children’s Special Services program, which serves children with disabilities.
[Sponsored] Luxury rehab means more than high-thread-count sheets and a view. The post Key Amenity Categories in Luxury Rehabs, According to The Sanctuary at Sedona appeared first on MedCity News.
Hours into the federal government shutdown, Julio Fuentes stood steps from the U.S. Capitol to deliver an urgent message about the Hispanic voting bloc that helped the GOP sweep into power last year. Those votes, he cautioned, are at risk if Congress doesn’t pass a law to preserve lower premiums on Affordable Care Act marketplace…
About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified. The post After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay appeared first on MedCity News.
It’s not just about awareness but also a call to action for patients, families, employers, payers and policymakers to modernize the systems that shape access to care. It must focus on connecting innovation with the infrastructure that governs approval, coverage and affordability. The post Rare Disease Day 2026: From Awareness to Access in a Volatile…
More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or delays in care. The post Payers Made a Bold Prior Auth Commitment in 2025. Here’s What to Expect in 2026 appeared first on MedCity News.
It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures. The post Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry appeared first on MedCity News.
Sarepta Therapeutics attributed the Phase 3 failure to the Covid-19 pandemic, during which many patients missed multiple doses of its Duchenne muscular dystrophy therapies. The company plans to discuss with the FDA traditional regulatory approvals based on the totality of data that includes real world evidence from the years these drugs have been commercially available…
THCB Gang is coming back! (I know you’ve all missed it) and we are starting with a bang. I’ll be meeting with six powerhouse women leaders in health care who’ve just issued a public statement signed by another 500+ women leaders in support of the Harris/Walz campaign. On the Gang today are Missy Krasner, digital…
Health and Human Services Secretary Robert F. Kennedy Jr.’s testimony before the Senate Finance Committee follows the ouster last week of the director of the Centers for Disease Control and Prevention, Susan Monarez. At least four other senior CDC officials resigned in protest. What are the biggest takeaways? What comes next? Tune in for a…